Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Histiocytoma, Malignant Fibrous × Trabectedin × Clear all

Phase

Phase NA 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Sarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1

Interventions

regorafenib 1 pegfilgrastim 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Radiotherapy, Conformal 1 Ifosfamide 1 Fluorodeoxyglucose F18 1 Doxorubicin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04008238 2026-03-06

PIPER

Institut Bergonié

Phase NA Completed

Hemangioendothelioma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡